LiverTwin Care Pathway helps clinicians identify patients at elevated risk for advanced fibrosis (F2+) in MASLD/MASH, streamlining the path to elastography and hepatology review while keeping you in full control.
Role-based views designed for each member of the care team
See at-risk patients, understand risk drivers, and order elastography with 1-2 clicks
Review incoming referrals prioritized by risk, triage efficiently, plan follow-up
Manage scheduling, track no-shows, send reminders, chase authorizations
Track KPIs, time-to-elastography, referral rates, and equity metrics
Clear visual risk tiers help prioritize clinical attention without diagnostic claims
FIB-4 < 1.3 — Routine monitoring, lifestyle modification recommended
Continue standard careFIB-4 1.3–2.67 — Consider elastography within 30 days for further evaluation
Elastography suggestedFIB-4 > 2.67 — Expedited elastography within 14 days, hepatology referral recommended
Urgent evaluation